Enterprise Value
375.2M
Cash
482.4M
Avg Qtr Burn
-29.09M
Short % of Float
15.04%
Insider Ownership
2.88%
Institutional Own.
-
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Bexotegrast (PLN-74809) Details Idiopathic pulmonary fibrosis | Phase 2b Update | |
Bexotegrast (PLN-74809) Details Primary sclerosing cholangitis | Phase 2a Update | |
PLN-101095 Details Cancer, Solid tumor/s | Phase 1a Data readout | |
Failed Discontinued |